CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 6,667 shares (grant or award)
- 4 Grant or award President and CEO acquired 27,027 shares (grant or award)
- 4 Open-market sale 10% owner sold 10,000 shares at $2.31 ($23,100)
- 4 Grant or award President and CEO acquired 7,440 shares (grant or award)
- 4 Grant or award President and CEO acquired 6,693 shares (grant or award)
- 4 Open-market sale 10% owner sold 10,000 shares at $2.04 ($20,400)
- 4 Grant or award President and CEO acquired 8,503 shares (grant or award)
- 4 Open-market sale Director sold 60,000 shares at $2.17 ($130,200)
- 4 Grant or award President and CEO acquired 7,610 shares (grant or award)
- 4 Open-market sale 10% owner sold 10,000 shares at $2.23 ($22,300)
- 4 Grant or award President and CEO acquired 7,440 shares (grant or award)
- 4 Grant or award President and CEO acquired 6,614 shares (grant or award)
- 4 Grant or award President and CEO acquired 6,410 shares (grant or award)
- 4 Grant or award President and CEO acquired 6,061 shares (grant or award)
- 4 Grant or award President and CEO acquired 6,562 shares (grant or award)
- 4 Grant or award President and CEO acquired 5,807 shares (grant or award)
Page 14 of 39 · 776 filings